Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by Sandpointon Apr 17, 2020 1:16pm
123 Views
Post# 30922670

RE:restructure point was 15,21$, anything u can get below that

RE:restructure point was 15,21$, anything u can get below thatThey did not make their partnership. As a result they had to shut down their Rockville office that did most of the research.  I read that not making the partnership was a sign that no one was willing to give them money. They were only willing to wait until the prcocess was completed. I hope this work out, but it resulted in the loss of a big part of the intellectual capability of the company. And that seems to me to mean that this companyt is really about selling the existing product. And it has no long term future. 
<< Previous
Bullboard Posts
Next >>